MedTrace Logo

Non-Inferiority Trial of Acute HFT Versus nCPAP

NCT01860560 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2023-05-03

No results posted yet for this study

Summary

Order randomized crossover non-inferiority study evaluating the acute efficacy of High Flow Therapy (HFT) as compared to nasal Continuous Positive Airway Pressure therapy (CPAP) in the management of apnea / hypopnea index (AHI).

Conditions

  • Mild-Moderate Obstructive Sleep Disordered Breathing

Interventions

DEVICE

High-Flow Therapy

Blower-based High Flow Therapy delivered by nasal cannula

DEVICE

Continuous Positive Airway Pressure

CPAP Therapy delivered by laboratory Positive Airway Pressure titration device.

Sponsors & Collaborators

  • Vapotherm, Inc.

    lead INDUSTRY

Principal Investigators

  • George Dungan, MPhil Med · Vapotherm, Inc.

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-05-31
Primary Completion
2014-01-31
Completion
2014-01-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01860560 on ClinicalTrials.gov